HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter T Katzmarzyk Selected Research
Peter T Katzmarzyk Research Topics
Disease
12
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 01/2003
7
Overweight
08/2014 - 05/2003
6
Obesity
01/2020 - 09/2003
5
Type 2 Diabetes Mellitus (MODY)
12/2021 - 01/2019
5
Hypertension (High Blood Pressure)
08/2014 - 08/2004
4
Myocardial Infarction
02/2013 - 09/2010
4
Heart Valve Diseases (Valvular Heart Disease)
02/2013 - 09/2010
3
Heart Failure
02/2014 - 01/2011
2
Stroke (Strokes)
01/2019 - 05/2014
2
Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 09/2005
2
Weight Gain
01/2016 - 03/2007
2
Insulin Resistance
03/2014 - 04/2010
1
COVID-19
11/2022
1
Fatigue
08/2022
1
Weight Loss (Weight Reduction)
12/2021
1
Heart Diseases (Heart Disease)
01/2020
1
Pediatric Obesity
01/2019
1
Hemorrhagic Stroke
01/2019
1
Noncommunicable Diseases
01/2019
1
Body Weight (Weight, Body)
01/2018
1
Wounds and Injuries (Trauma)
06/2016
1
Coronary Disease (Coronary Heart Disease)
02/2014
1
Inflammation (Inflammations)
01/2012
1
Lung Diseases (Lung Disease)
09/2010
1
Neoplasms (Cancer)
04/2008
1
Sarcopenia
01/2004
Drug/Important Bio-Agent (IBA)
14
Cholesterol
IBA
08/2022 - 01/2003
13
Glucose (Dextrose)
FDA Link
Generic
01/2020 - 05/2003
11
Triglycerides (Triacylglycerol)
IBA
03/2014 - 05/2003
9
HDL Cholesterol
IBA
01/2021 - 10/2003
4
Insulin (Novolin)
FDA Link
12/2021 - 08/2004
3
ORALIT (ORS)
IBA
01/2020 - 02/2005
3
Antihypertensive Agents (Antihypertensives)
IBA
11/2013 - 09/2010
3
antineoplaston A10 (A 10)
IBA
03/2007 - 09/2003
2
Indicators and Reagents (Reagents)
IBA
11/2022 - 12/2021
2
Biomarkers (Surrogate Marker)
IBA
06/2016 - 08/2014
2
C-Reactive Protein
IBA
03/2014 - 01/2012
2
oxidized low density lipoprotein
IBA
04/2010 - 05/2003
2
Adenosine Triphosphate (ATP)
IBA
09/2005 - 09/2003
1
Hemoglobins (Hemoglobin)
IBA
11/2020
1
Sodium
IBA
01/2020
1
Sodium-Glucose Transporter 2 Inhibitors
IBA
01/2020
1
N- (phenylacetyl)glycylaziridine- 2- carboxylate phenylmethyl ester (PAGAC)
IBA
01/2019
1
Lipids
IBA
01/2018
1
Sugars
IBA
11/2016
1
Buffers
IBA
01/2016
1
Tea
IBA
01/2011
1
Coffee
FDA Link
01/2011
1
lipoprotein cholesterol
IBA
04/2010
1
HDL Lipoproteins
IBA
04/2009
1
Biological Factors
IBA
03/2009
1
LDL Cholesterol
IBA
08/2004
1
Blood Glucose (Blood Sugar)
IBA
10/2003
Therapy/Procedure
1
Surgical Amputation (Amputations)
11/2020
1
Ambulatory Care (Outpatient Care)
11/2016
1
Glycemic Control
02/2014
1
Fat-Restricted Diet (Diet, Fat Restricted)
03/2010
1
Therapeutics
07/2009
1
Drug Therapy (Chemotherapy)
09/2005